{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:38:15Z","timestamp":1764859095104,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,11,10]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>We present a 21-year-old woman diagnosed with Philadelphia (Ph) chromosome-like CD20 positive B-cell acute lymphoblastic leukaemia (ALL). She was a Jehovah\u2019s Witness (JW) and declined all blood product transfusion support. She was initiated on the CALGB 10403 chemotherapy protocol for her ALL. She received darbepoetin alfa and romiplostim as supportive therapies for her disease\/chemotherapy-associated anaemia and thrombocytopaenia. A complete remission was achieved with negative minimal residual disease and she remains in remission 18 months after diagnosis. This case report describes the successful treatment of an adult JW with Ph-like CD20 +B\u2009cell ALL, in the absence of blood product transfusions, using growth factor support.<\/jats:p>","DOI":"10.1136\/bcr-2018-226497","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T17:19:47Z","timestamp":1545153587000},"page":"e226497","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah\u2019s Witness"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"isrctn73545489","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct02578901","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8762-577X","authenticated-orcid":false,"given":"Nivedita","family":"Arora","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao C","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA"},{"name":"Parkland Health and Hospital System, Dallas, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA"},{"name":"Parkland Health and Hospital System, Dallas, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"2025082707550194000_11.1.e226497.1","unstructured":"JW.org. 2016 https:\/\/www.jw.org\/en\/publications\/books\/2017-yearbook\/jehovahs-witnesses-service-report-2016\/"},{"key":"2025082707550194000_11.1.e226497.2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200209000-00009"},{"key":"2025082707550194000_11.1.e226497.3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0902-4441.2003.00211.x","article-title":"Tailored therapy of adult acute leukaemia in Jehovah\u2019s Witnesses: unjustified reluctance to treat","volume":"72","author":"Laszlo","year":"2004","journal-title":"Eur J Haematol"},{"key":"2025082707550194000_11.1.e226497.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00634.x"},{"key":"2025082707550194000_11.1.e226497.5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1179\/1973947813Y.0000000130","article-title":"Acute lymphoblastic leukaemia in a Jehovah\u2019s Witness: a management dilemma","volume":"26","author":"Zhou","year":"2014","journal-title":"J Chemother"},{"key":"2025082707550194000_11.1.e226497.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-743252"},{"key":"2025082707550194000_11.1.e226497.7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11912-017-0589-2","article-title":"Philadelphia-like acute lymphoblastic leukemia in adults","volume":"19","author":"Herold","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"2025082707550194000_11.1.e226497.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6945"},{"key":"2025082707550194000_11.1.e226497.9","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S106810"},{"key":"2025082707550194000_11.1.e226497.10","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.481065"},{"key":"2025082707550194000_11.1.e226497.11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ajh.24889","article-title":"Treatment of individuals who cannot receive blood products for religious or other reasons","volume":"92","author":"Scharman","year":"2017","journal-title":"Am J Hematol"},{"key":"2025082707550194000_11.1.e226497.12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/bjh.14792","article-title":"Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy","volume":"178","author":"Fenaux","year":"2017","journal-title":"Br J Haematol"},{"key":"2025082707550194000_11.1.e226497.13","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00277-017-2953-6","article-title":"Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists","volume":"96","author":"Rodeghiero","year":"2017","journal-title":"Ann Hematol"},{"key":"2025082707550194000_11.1.e226497.14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1537-2995.2011.03382.x","article-title":"Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia","volume":"52","author":"Berthelot-Richer","year":"2012","journal-title":"Transfusion"},{"key":"2025082707550194000_11.1.e226497.15","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1002\/ajh.25022","article-title":"A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia","volume":"93","author":"Miao","year":"2018","journal-title":"Am J Hematol"},{"key":"2025082707550194000_11.1.e226497.16","unstructured":"ClinicalTrials.gov. ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. https:\/\/clinicaltrials.gov\/ct2\/home"},{"key":"2025082707550194000_11.1.e226497.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.04.016"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bcr-2018-226497","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-226497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:55:08Z","timestamp":1756306508000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-226497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,7]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/bcr-2018-226497"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-226497","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}